• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: LIVANOVA USA, INC. LEAD MODEL 7304

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

LIVANOVA USA, INC. LEAD MODEL 7304 Back to Search Results
Model Number 7304-20
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problems Foreign Body Reaction (1868); Inflammation (1932); Thrombosis/Thrombus (4440); Subcutaneous Nodule (4548)
Event Date 02/09/2021
Event Type  Injury  
Event Description
It was reported that the patient experienced thrombosis of the right and left internal jugular vein.The event was noted to be probably related to the implant and not related to stimulation.It was also noted to be possibly related to underlying disease as the patient has slow flow due to heart failure.The event was noted to be moderate.Medication was provided and the event is recovering/ resolving.It was also reported that the patient had inflammation which was noted to be probably related to implant.It was noted to be a serious adverse event and is recovering/ resolving.No further relevant information has been received to date.
 
Event Description
It was noted that the thrombosis resolved.It was noted that there was an inflammatory mass ipsilateral to the implantation side.The event is severe and life threatening and started on (b)(6) 2021.It was noted to be probably related to the implant, not related to underlying disease or other study procedure.The event required medication and hospitalization, and it is recovering/resolving.Other contributing factors were noted to be possible thrombophilia and collagen disorder.Summary was given of the events.It states that the patient was implanted on (b)(6) /2021 and had jugular vein thrombosis, and on (b)(6)2021 the patient was treated with the anticoagulation drug ribaroxaban.The patient initially had improvement but had worsening of facial swelling on 5/5/2021 and had a ct on 5/16/2021 which showed inflammatory mass in the right neck area which was not present before.The patient had exploratory laryngoscopy and biopsy, and the patient was intubated and stable in the icu on 5/18/2021.No further relevant information has been received to date.
 
Manufacturer Narrative
Health effect - impact code :f2203.
 
Event Description
It was noted that the inflammatory mass resolved.No further relevant information has been received to date.
 
Event Description
It was noted that the thrombosis event is possibly related to stimulation, probably related to implant.No further relevant information has been received to date.
 
Event Description
The event date for the facial edema was updated.The event is noted to be probably related to implant, possibly related to device.No further relevant information has been received to date.
 
Event Description
Information was received noting that the patient has a disturbing cough with vns stimulation.It was also observed that he has more intense facial edema so he was referred to have a new echo to check his jugular veins again.It is noted that the edema is possibly related to implant as it happened after implantation for the first time in his life, but it is also possible that the nerve stimulation is causing inflammation.No action was taken for the events.Other events noted were thrombosis of jugular veins bilateral, possibly related to implant; thrombus size increase in cervical echo possibly related to implant, present thrombus / no evidence of another etiology; worsening of thrombosis in cervical echo and ct scan, possibly related to implant.Worsening of thrombosis began after inflammation.No further relevant information has been received to date.
 
Event Description
It was noted that medication was provided for the facial edema.Thrombosis of jugular veins bilateral resolved.The increase in thrombus size and coughing events had stop dates added.No further relevant information has been received to date.
 
Manufacturer Narrative
Correction: g3 (aware date) for supplemental report #7 should have been (b)(6) 2022.
 
Event Description
The increased thrombus size event was updated to "not recovered/resolved".No further relevant information has been received to date.
 
Event Description
Final assessment of the event of inflammation mass ipsilateral to the implantation site was probably related to the vitaria implant.The report of facial edema was updated to note that no treatment was required for the event.No additional relevant information has been received.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
LEAD MODEL 7304
Type of Device
LEAD
Manufacturer (Section D)
LIVANOVA USA, INC.
100 cyberonics blvd
houston TX 77058
Manufacturer (Section G)
LIVANOVA USA, INC.
100 cyberonics blvd
suite 600
houston TX 77058
Manufacturer Contact
dana sprague
100 cyberonics blvd
suite 600
houston, TX 77058
2816672681
MDR Report Key11901472
MDR Text Key253176064
Report Number1644487-2021-00737
Device Sequence Number1
Product Code MUZ
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
P970003
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Foreign,Study,Health Professional,Company Representative
Reporter Occupation Other
Type of Report Initial,Followup,Followup,Followup,Followup
Report Date 10/28/2022
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Lay User/Patient
Device Expiration Date07/16/2023
Device Model Number7304-20
Device Lot Number204982
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? No
Event Location Other
Initial Date Manufacturer Received 05/05/2021
Initial Date FDA Received05/28/2021
Supplement Dates Manufacturer Received06/01/2021
07/13/2021
08/01/2021
10/21/2021
12/02/2021
12/27/2021
12/27/2021
06/06/2022
12/27/2021
Supplement Dates FDA Received06/16/2021
07/13/2021
08/26/2021
11/15/2021
12/16/2021
01/21/2022
02/25/2022
06/16/2022
10/28/2022
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured07/30/2019
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Hospitalization; Other;
Patient Age55 YR
Patient SexMale
-
-